• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Rekvina Labs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3082.0
  • ISIN : INE092O01028
4.50 0 (0.00%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    4.50

  • Today’s High

    4.50

  • Open

    4.50

  • Perv Close

    4.50

  • 52W Low

    0.00

  • 52W High

    0.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    -0.12

  • Debt-Equity Ratio

    0.00

  • AGM Date

    13-Dec-2021

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    2.71

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.01

  • BV (₹)

    -0.10

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.02

  • NP Var(%)

    -2101.0

  • Div%

    0.0

  • CPS (₹)

    0.00

  • EPS (₹)

    0.00

  • Traded Value (₹ in Lakhs)

    2.71

  • 52 Week High

    0.00

  • 52 Week Low

    0.00

  • Price BSE

    5.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    2.71

  • P/C Ratio

    -183.80

  • P/E Ratio

    -183.80

  • Price Vs.BV

    0.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2018 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.15 0.02
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.00 0.00 0.00 0.00 0.15 0.02
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.00 0.00 0.00 0.00 0.08 0.00
Other Manufacturing Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.02 0.00 0.08 0.04 0.03 0.10
Miscellaneous Expenses 0.00 0.00 0.00 0.03 0.04 0.00
Employee Benefit Expenses 0.00 0.00 0.00 0.00 0.08 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 0.02 0.00 0.08 0.06 0.15 0.10
Operating Profit -0.02 0.00 -0.08 -0.06 0.00 -0.08
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.02 0.00 -0.08 -0.06 0.00 -0.08
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax -0.02 0.00 -0.08 -0.06 0.00 -0.08
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.02 0.00 -0.08 -0.06 0.00 -0.08
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -0.02 0.00 -0.08 -0.06 0.00 -0.08
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -3.04 -3.04 -2.96 -2.90 -2.90 -2.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -3.06 -3.04 -3.04 -2.96 -2.90 -2.65
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.03 0.00 -0.13 -0.11 0.00 0.00
Earnings Per Share(Adj)-Unit Curr - - - -0.11 0.00 -
Book Value -0.01 0.02 0.02 0.15 0.26 0.67
Book Value(Adj)-Unit Curr - - - 0.15 0.26 -

Shareholding Pattern

  • Promoter Group

    41.30%

  • Public Share Holding

    58.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,489,483 41.30 2,489,483 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,489,483 41.30 2,489,483 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 501,213 8.31 500,213 8
Clearing Members 1,000 0.02 1,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,600 0.06 3,600 3
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 375,412 6.23 375,412 18
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,498,360 24.86 1,498,360 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,158,932 19.23 723,132 2,385
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,538,517 58.70 3,101,717 2,424
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,028,000 100.00 5,591,200 2,427

Company Background

Rekvina Labs LtdPharmaceuticals - Indian - Formulations

  • Rekvina Labs Ltd
  • BSE Code : 3082.0
  • ISIN : INE092O01028

  • Incorporation Year

    1988

  • Registered Office

    328 Paradise Complex
    Sayajigunj, Vadodara,
    Gujarat-390005

  • Telephone

    91-265-2362966

  • FAX

  • Chairman

  • Managing Director

    Amit Mukeshbhai Shah

  • Company Secretary

  • Auditor

    Jigar Adhyaru & Co/TDK & Co

  • Face Value

    5

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Rekvina Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Rekvina Labs 4.50 0.00 0.00 -28.13 0.00
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92